Work-place social capital and smoking cessation: the Finnish Public Sector Study

Addiction
Anne KouvonenMika Kivimäki

Abstract

To examine whether high social capital at work is associated with an increased likelihood of smoking cessation in baseline smokers. Prospective cohort study. Finland. A total of 4853 employees who reported to be smokers in the baseline survey in 2000-2002 (response rate 68%) and responded to a follow-up survey on smoking status in 2004-2005 (response rate 77%). Work-place social capital was assessed using a validated and psychometrically tested eight-item measure. Control variables included sex, age, socio-economic position, marital status, place of work, heavy drinking, physical activity, body mass index and physician-diagnosed depression. In multi-level logistic regression models adjusted for all the covariates, the odds for being a non-smoker at follow-up were 1.26 [95% confidence interval (CI)=1.03-1.55] times higher for baseline smokers who reported high individual-level social capital than for their counterparts with low social capital. In an analysis stratified by socio-economic position, a significant association between individual-level social capital and smoking cessation was observed in the high socio-economic group [odds ratio (OR) (95% CI)=1.63 (1.01-2.63)], but not in intermediate [(OR=1.10 (0.83-1.47)] or low soc...Continue Reading

References

Jul 1, 1988·Psychosomatic Medicine·M KoskenvuoH Langinvainio
Jan 1, 1985·Social Science & Medicine·M WestmanA Shirom
Jul 1, 1994·Addictive Behaviors·T L PokorskiR L Bertholf
Mar 1, 1994·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·I M LipkusI C Siegler
Oct 7, 1997·American Journal of Public Health·I KawachiD Prothrow-Stith
Aug 5, 1999·American Journal of Public Health·I KawachiR Glass
Aug 19, 1999·Journal of the National Cancer Institute·A W Bergen, N Caporaso
Feb 22, 2000·Annals of the New York Academy of Sciences·I Kawachi
Sep 14, 2000·Health & Place·K LochnerB P Kennedy
Oct 25, 2000·Scandinavian Journal of Public Health·M LindströmG Berglund
Sep 21, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·I Kawachi, L F Berkman
Jan 23, 2002·American Journal of Health Promotion : AJHP·Glorian SorensenJill Avrunin
Feb 21, 2002·Journal of Epidemiology and Community Health·E VartiainenP Puska
Feb 28, 2002·Addiction·Martin LindströmUNKNOWN Malmö Shoulder-Neck Study Group
Nov 26, 2002·American Journal of Epidemiology·Urho M KujalaMarkku Koskenvuo
Jan 24, 2003·Journal of Epidemiology and Community Health·A SkrabskiI Kawachi
Jan 30, 2003·American Journal of Public Health·Debbie A LawlorGeorge Davey Smith
May 31, 2003·Journal of Epidemiology and Community Health·J Wardle, A Steptoe
Dec 17, 2003·Scandinavian Journal of Public Health·Martin LindströmJuan Merlo
Jul 30, 2004·International Journal of Epidemiology·Ichiro KawachiS V Subramanian
Sep 7, 2004·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·John F Helliwell, Robert D Putnam
Mar 12, 2005·Annual Review of Public Health·John Lynch, George Davey Smith
Jun 1, 2005·European Journal of Public Health·A Jeanne M van LoonJohan Ormel
Jul 26, 2005·Scandinavian Journal of Public Health·Ellis JanzonLars Janzon
Feb 24, 2006·Drug and Alcohol Review·Kay WilhelmFrances Kay-Lambkin
Feb 25, 2006·Occupational and Environmental Medicine·U JohnC Meyer
Oct 4, 2006·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Austin S BaldwinHarry A Lando
Oct 14, 2006·BMC Public Health·Anne KouvonenRichard G Wilkinson
Jan 12, 2007·Journal of Occupational and Environmental Medicine·Michael T HalpernJordana K Schmier
Jul 7, 2007·BMJ : British Medical Journal·Paul Aveyard, Robert West
Sep 14, 2007·Scandinavian Journal of Public Health·Martin Lindström, Ellis Janzon
Apr 17, 2008·American Journal of Epidemiology·Anne KouvonenMika Kivimäki
Apr 22, 2008·American Journal of Health Promotion : AJHP·Ari VäänänenJussi Vahtera

❮ Previous
Next ❯

Citations

Jun 29, 2013·BMC Public Health·Tarja NieminenSeppo Koskinen
Jul 6, 2013·International Archives of Occupational and Environmental Health·Jessica Janice TangSara MacLennan
Mar 27, 2012·Journal of Epidemiology·Hiroshi MurayamaIchiro Kawachi
Jun 22, 2013·Journal of Occupational and Environmental Medicine·Bart De ClercqLutgart Braeckman
Apr 25, 2012·Journal of Hypertension·Tuula OksanenMika Kivimäki
Jan 30, 2016·European Journal of Public Health·Reiner RuguliesJakob Bue Bjorner
May 2, 2013·Social Science & Medicine·Allison R WebelRobert A Salata
Nov 6, 2014·International Journal of Epidemiology·Minkyoung ChoiJuan P Casas
May 9, 2016·Social Psychiatry and Psychiatric Epidemiology·Marcos Pascoal PattussiIchiro Kawachi
Jul 28, 2016·Cadernos de saúde pública·Ester Paiva SoutoRosane Härter Griep
Sep 17, 2015·Cadernos de saúde pública·Mathias Roberto LochFernando Rodríguez-Artalejo
Jun 24, 2017·International Journal of Epidemiology·Ulla Arthur HvidtfeldtNaja Hulvej Rod
Aug 11, 2018·Journal of Occupational and Environmental Medicine·Yongkai ZhuHua Fu
Jan 3, 2020·Journal of Occupational and Environmental Medicine·Sehee HanJong Won Lee
Jul 19, 2018·International Archives of Occupational and Environmental Health·Heidi JanssensEls Clays
Jun 27, 2018·BMC Public Health·Mojgan FirouzbakhtReza Sadeghian
Jan 18, 2019·International Journal of Environmental Research and Public Health·Toni AltermanKevin M Kelly
Jan 8, 2021·International Archives of Occupational and Environmental Health·Mandy van den BergeGerben Hulsegge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.